191 related articles for article (PubMed ID: 21617991)
1. Sclerostin levels during growth in children.
Kirmani S; Amin S; McCready LK; Atkinson EJ; Melton LJ; Müller R; Khosla S
Osteoporos Int; 2012 Mar; 23(3):1123-30. PubMed ID: 21617991
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
Coulson J; Bagley L; Barnouin Y; Bradburn S; Butler-Browne G; Gapeyeva H; Hogrel JY; Maden-Wilkinson T; Maier AB; Meskers C; Murgatroyd C; Narici M; Pääsuke M; Sassano L; Sipilä S; Al-Shanti N; Stenroth L; Jones DA; McPhee JS
Osteoporos Int; 2017 Sep; 28(9):2683-2689. PubMed ID: 28585053
[TBL] [Abstract][Full Text] [Related]
3. Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.
Ma YH; Schwartz AV; Sigurdsson S; Hue TF; Lang TF; Harris TB; Rosen CJ; Vittinghoff E; Eiriksdottir G; Hauksdottir AM; Siggeirsdottir K; Sigurdsson G; Oskarsdottir D; Napoli N; Palermo L; Gudnason V; Li X
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2584-90. PubMed ID: 25144629
[TBL] [Abstract][Full Text] [Related]
4. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
Polyzos SA; Anastasilakis AD; Bratengeier C; Woloszczuk W; Papatheodorou A; Terpos E
Osteoporos Int; 2012 Mar; 23(3):1171-6. PubMed ID: 21305266
[TBL] [Abstract][Full Text] [Related]
5. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.
Szulc P; Boutroy S; Vilayphiou N; Schoppet M; Rauner M; Chapurlat R; Hamann C; Hofbauer LC
J Bone Miner Res; 2013 Aug; 28(8):1760-70. PubMed ID: 23408601
[TBL] [Abstract][Full Text] [Related]
6. Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.
Fazeli PK; Ackerman KE; Pierce L; Guereca G; Bouxsein M; Misra M
Osteoporos Int; 2013 Sep; 24(9):2433-40. PubMed ID: 23579340
[TBL] [Abstract][Full Text] [Related]
7. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
[TBL] [Abstract][Full Text] [Related]
8. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
[TBL] [Abstract][Full Text] [Related]
9. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus.
Pereira M; Gohin S; Lund N; Hvid A; Smitham PJ; Oddy MJ; Reichert I; Farlay D; Roux JP; Cleasby ME; Chenu C
Osteoporos Int; 2017 Jan; 28(1):309-320. PubMed ID: 27468901
[TBL] [Abstract][Full Text] [Related]
11. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.
Kashii M; Matuso Y; Sugiura T; Fujimori T; Nagamoto Y; Makino T; Kaito T; Ebina K; Iwasaki M; Yoshikawa H
J Bone Miner Metab; 2016 May; 34(3):315-24. PubMed ID: 26040409
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.
Register TC; Hruska KA; Divers J; Bowden DW; Palmer ND; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Dietzen DJ; Langefeld CD; Freedman BI
J Clin Endocrinol Metab; 2014 Jan; 99(1):315-21. PubMed ID: 24178795
[TBL] [Abstract][Full Text] [Related]
13. Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans.
Roforth MM; Fujita K; McGregor UI; Kirmani S; McCready LK; Peterson JM; Drake MT; Monroe DG; Khosla S
Bone; 2014 Feb; 59():1-6. PubMed ID: 24184314
[TBL] [Abstract][Full Text] [Related]
14. Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures.
Heilmeier U; Carpenter DR; Patsch JM; Harnish R; Joseph GB; Burghardt AJ; Baum T; Schwartz AV; Lang TF; Link TM
Osteoporos Int; 2015 Apr; 26(4):1283-93. PubMed ID: 25582311
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus.
García-Martín A; Rozas-Moreno P; Reyes-García R; Morales-Santana S; García-Fontana B; García-Salcedo JA; Muñoz-Torres M
J Clin Endocrinol Metab; 2012 Jan; 97(1):234-41. PubMed ID: 22031520
[TBL] [Abstract][Full Text] [Related]
16. 24-hour profile of serum sclerostin and its association with bone biomarkers in men.
Swanson C; Shea SA; Wolfe P; Markwardt S; Cain SW; Munch M; Czeisler CA; Orwoll ES; Buxton OM
Osteoporos Int; 2017 Nov; 28(11):3205-3213. PubMed ID: 28744601
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
Durosier C; van Lierop A; Ferrari S; Chevalley T; Papapoulos S; Rizzoli R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
[TBL] [Abstract][Full Text] [Related]
18. Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.
Faje AT; Fazeli PK; Katzman DK; Miller KK; Breggia A; Rosen CJ; Mendes N; Klibanski A; Misra M
Bone; 2012 Sep; 51(3):474-9. PubMed ID: 22728230
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin serum levels in prostate cancer patients and their relationship with sex steroids.
García-Fontana B; Morales-Santana S; Varsavsky M; García-Martín A; García-Salcedo JA; Reyes-García R; Muñoz-Torres M
Osteoporos Int; 2014 Feb; 25(2):645-51. PubMed ID: 23903956
[TBL] [Abstract][Full Text] [Related]
20. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
